Ovarian Seromucinous Borderline Tumor and Clear Cell Carcinoma: An Unusual Combination

Ovarian seromucinous borderline tumors (SMBTs) are rare. They architecturally resemble serous borderline tumors but are much more frequently associated with endometriosis. The coexistence of other tumors with seromucinous tumors is also extremely rare. Here, we report an unusual combination of bilat...

Full description

Saved in:
Bibliographic Details
Main Authors: Eriko Nakamura, Yuichiro Sato, Sayaka Moriguchi, Atsushi Yamashita, Takashi Higo, Yujiro Asada
Format: Article
Language:English
Published: Wiley 2015-01-01
Series:Case Reports in Obstetrics and Gynecology
Online Access:http://dx.doi.org/10.1155/2015/690891
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832548574179622912
author Eriko Nakamura
Yuichiro Sato
Sayaka Moriguchi
Atsushi Yamashita
Takashi Higo
Yujiro Asada
author_facet Eriko Nakamura
Yuichiro Sato
Sayaka Moriguchi
Atsushi Yamashita
Takashi Higo
Yujiro Asada
author_sort Eriko Nakamura
collection DOAJ
description Ovarian seromucinous borderline tumors (SMBTs) are rare. They architecturally resemble serous borderline tumors but are much more frequently associated with endometriosis. The coexistence of other tumors with seromucinous tumors is also extremely rare. Here, we report an unusual combination of bilateral ovarian SMBT and clear cell carcinoma associated with polypoid endometriosis of the colon, in a 62-year-old woman. There was no transitional lesion between the two tumors. Immunohistochemistry showed different staining patterns in tumor components. Seromucinous tumor cells were positive for estrogen receptor (ER) and progesterone receptor (PgR) but negative for Napsin A, p504S, and HNF1B. Clear cell tumor cells were positive for Napsin A and p504S and focally positive for HNF1B but negative for ER and PgR. Loss of ARID1A expression was not observed in SMBTs, clear cell tumors, or endometriosis. These findings suggest that these tumors arose from separate endometriosis foci and collided within the same ovary. To the best of our knowledge, this is the first case of this unusual combination of ovarian seromucinous tumor and clear cell carcinoma to be reported in the English literature.
format Article
id doaj-art-e52f05f869f14669a1dcf791e9ccb475
institution Kabale University
issn 2090-6684
2090-6692
language English
publishDate 2015-01-01
publisher Wiley
record_format Article
series Case Reports in Obstetrics and Gynecology
spelling doaj-art-e52f05f869f14669a1dcf791e9ccb4752025-02-03T06:13:51ZengWileyCase Reports in Obstetrics and Gynecology2090-66842090-66922015-01-01201510.1155/2015/690891690891Ovarian Seromucinous Borderline Tumor and Clear Cell Carcinoma: An Unusual CombinationEriko Nakamura0Yuichiro Sato1Sayaka Moriguchi2Atsushi Yamashita3Takashi Higo4Yujiro Asada5Department of Pathology, University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki 889-1692, JapanDepartment of Diagnostic Pathology, Miyazaki University Hospital, University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki 889-1692, JapanDepartment of Diagnostic Pathology, Miyazaki University Hospital, University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki 889-1692, JapanDepartment of Pathology, University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki 889-1692, JapanDepartment of Gynecology and Obstetrics, Koga Hospital, 1749-1 Sudaki, Ikeuchi, Miyazaki 880-0041, JapanDepartment of Pathology, University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki 889-1692, JapanOvarian seromucinous borderline tumors (SMBTs) are rare. They architecturally resemble serous borderline tumors but are much more frequently associated with endometriosis. The coexistence of other tumors with seromucinous tumors is also extremely rare. Here, we report an unusual combination of bilateral ovarian SMBT and clear cell carcinoma associated with polypoid endometriosis of the colon, in a 62-year-old woman. There was no transitional lesion between the two tumors. Immunohistochemistry showed different staining patterns in tumor components. Seromucinous tumor cells were positive for estrogen receptor (ER) and progesterone receptor (PgR) but negative for Napsin A, p504S, and HNF1B. Clear cell tumor cells were positive for Napsin A and p504S and focally positive for HNF1B but negative for ER and PgR. Loss of ARID1A expression was not observed in SMBTs, clear cell tumors, or endometriosis. These findings suggest that these tumors arose from separate endometriosis foci and collided within the same ovary. To the best of our knowledge, this is the first case of this unusual combination of ovarian seromucinous tumor and clear cell carcinoma to be reported in the English literature.http://dx.doi.org/10.1155/2015/690891
spellingShingle Eriko Nakamura
Yuichiro Sato
Sayaka Moriguchi
Atsushi Yamashita
Takashi Higo
Yujiro Asada
Ovarian Seromucinous Borderline Tumor and Clear Cell Carcinoma: An Unusual Combination
Case Reports in Obstetrics and Gynecology
title Ovarian Seromucinous Borderline Tumor and Clear Cell Carcinoma: An Unusual Combination
title_full Ovarian Seromucinous Borderline Tumor and Clear Cell Carcinoma: An Unusual Combination
title_fullStr Ovarian Seromucinous Borderline Tumor and Clear Cell Carcinoma: An Unusual Combination
title_full_unstemmed Ovarian Seromucinous Borderline Tumor and Clear Cell Carcinoma: An Unusual Combination
title_short Ovarian Seromucinous Borderline Tumor and Clear Cell Carcinoma: An Unusual Combination
title_sort ovarian seromucinous borderline tumor and clear cell carcinoma an unusual combination
url http://dx.doi.org/10.1155/2015/690891
work_keys_str_mv AT erikonakamura ovarianseromucinousborderlinetumorandclearcellcarcinomaanunusualcombination
AT yuichirosato ovarianseromucinousborderlinetumorandclearcellcarcinomaanunusualcombination
AT sayakamoriguchi ovarianseromucinousborderlinetumorandclearcellcarcinomaanunusualcombination
AT atsushiyamashita ovarianseromucinousborderlinetumorandclearcellcarcinomaanunusualcombination
AT takashihigo ovarianseromucinousborderlinetumorandclearcellcarcinomaanunusualcombination
AT yujiroasada ovarianseromucinousborderlinetumorandclearcellcarcinomaanunusualcombination